A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The breakpoints of Df(3L)BSC832 predicted from the Release 5 genomic coordinates of the progenitor PBac{RB}Sgf11e01308 and P{XP}CG3902d00813 transposable element insertion sites are 3L:18674910--18674961 ;18888298--18888499 and the cytological breakpoints predicted from these coordinates are 75D6;75E4.